However, the largest Phase IIb trial involving 536 subjects failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading Metabolic Pharmaceuticals to terminate development in 2007
Depends on your situation: If you struggle with hunger and portion control, GLP-1 agonists are more effective
Can be used to prevent or treat common colds and recurrent viral infections, skin aging and wrinkles, fatigue, Vitamin C deficiency and fibromyalgia
The compound could theoretically interact with medications affecting NAD+ metabolism, energy pathways, or the enzymes responsible for its clearance from the body
doi: 10.1016/s0167-0115(01)00358-5
Saving money on junk food